NIMOTUZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Possibly Marketed Outside US

Possibly Marketed Outside US

Approval Year

Substance Class	Protein Created by `admin` on `Mon Mar 31 21:03:22 GMT 2025` Edited by `admin` on `Mon Mar 31 21:03:22 GMT 2025`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	6NS400BXKH
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

NIMOTUZUMAB

Official Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER

Preferred Name

English

THERALOC

Code

English

THERACIM-HR3

Code

English

Nimotuzumab [WHO-DD]

Common Name

English

IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULPHIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER

Common Name

English

OSAG 101

Code

English

NIMOTUZUMAB [MI]

Common Name

English

nimotuzumab [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C20401

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

FDA ORPHAN DRUG

192504

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

NCI_THESAURUS

C2167

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

EU-Orphan Drug

EU/3/08/550

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

FDA ORPHAN DRUG

487915

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

Code System Code Type Description

MERCK INDEX

m7908

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

Merck Index

CAS

780758-10-3

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

CAS

828933-51-3

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

SUPERSEDED

IUPHAR

7988

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

SMS_ID

100000089660

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

NCI_THESAURUS

C2733

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

MESH

C501466

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

FDA UNII

6NS400BXKH

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

INN

8545

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

WIKIPEDIA

NIMOTUZUMAB

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

DRUG BANK

DB06192

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

EVMPD

SUB26699

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

ChEMBL

CHEMBL2108359

Created by admin on Mon Mar 31 21:03:22 GMT 2025 , Edited by admin on Mon Mar 31 21:03:22 GMT 2025

PRIMARY

From	To
1_22	1_96
1_150	1_206
1_226	3_219
1_232	2_232
1_235	2_235
1_267	1_327
1_373	1_431
2_22	2_96
2_150	2_206
2_226	4_219
2_267	2_327
2_373	2_431
3_23	3_93
3_139	3_199
4_23	4_93
4_139	4_199

Related Record Type Details


					RO03J093CP

EPIDERMAL GROWTH FACTOR RECEPTOR

TARGET -> INHIBITOR

Interaction Type:

BINDING

Amount:

Related Record Type Details


					6NS400BXKH

ACTIVE MOIETY

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT:ESTIMATE	CHEMICAL
Molecular Formula	CHEMICAL